Oral Session 2-9C Multiple Myeloma: Basic (Novel Molecular Targets）

[OS2-9C-5] Molecular mechanisms of dual inhibition of Akt and PRC2 in the treatment of multiple myeloma

Mohamed Rizk¹, Ola Rizq², Motohiko Oshima¹, Yaeko Nakajima-Takagi¹, Atsunori Saraya³, Yusuke Isshiki⁴, Atsushi Iwama¹, Naoya Mimura⁵ (1.Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan, 2.Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA, Boston, Boston, United States of America, 3.Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan, Chiba, Chiba, Japan, 4.Department of Hematology, Oami Municipal Hospital, Chiba, Japan, Chiba, Chiba, Japan, 5.Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan, Chiba, Chiba, Japan)